CAS 139076-62-3
:Octocog alfa
Description:
Octocog alfa, also known as recombinant factor VIII, is a therapeutic protein used primarily in the treatment of hemophilia A, a genetic disorder characterized by a deficiency in clotting factor VIII. This recombinant form is produced using recombinant DNA technology, allowing for a more consistent and safer product compared to plasma-derived factor VIII. Octocog alfa functions by promoting blood coagulation, thereby helping to prevent or control bleeding episodes in affected individuals. It is characterized by its high purity and specific activity, which are essential for effective treatment. The substance is typically administered via intravenous injection and is available in various formulations to accommodate different patient needs. Common side effects may include allergic reactions, particularly in patients with pre-existing antibodies to factor VIII. Overall, Octocog alfa represents a significant advancement in hemophilia management, providing patients with a reliable means to maintain hemostasis and improve their quality of life.
Formula:Unspecified
Synonyms:- BAY-w 6240
- Octocog alfa
- Helixate NexGen
- Kogenate
- Helixate
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
Octocog alfa
CAS:Octocog alfa, a second-generation, full-length recombinant antihemophilic factor VIII (AHF), is utilized for the treatment of Hemophilia A [1].Color and Shape:Solid
